Skip to main content
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes Care

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes Care
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Meta-analysis

Dietary Intervention in Patients With Gestational Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Clinical Trials on Maternal and Newborn Outcomes

  1. Luciana Verçoza Viana⇑,
  2. Jorge Luiz Gross and
  3. Mirela Jobim Azevedo
  1. Division of Endocrinology, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil
  1. Corresponding author: Luciana Verçoza Viana, vercoza{at}yahoo.com.
Diabetes Care 2014 Dec; 37(12): 3345-3355. https://doi.org/10.2337/dc14-1530
PreviousNext
  • Article
  • Figures & Tables
  • Suppl Material
  • Info & Metrics
  • PDF
Loading

Article Figures & Tables

Figures

  • Tables
  • Figure 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1

    Flow diagram of literature search to identify RCTs evaluating the effect of diet in patients with GDM.

  • Figure 2
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2

    Forest plots of dietary intervention for patients with GDM: low GI diet (A), energy restriction diet (B), and low carbohydrate diet (C).

Tables

  • Figures
  • Table 1

    Characteristics of the studies according to dietary intervention in GDM

    Author, yearSample characteristicsGDM criteriaDiet characteristicsMaternal outcomesNewborn outcomes
    Dietary intervention: low GI
    Perichart-Perera, 2012n = 48 Age = 33.2 ± 5.1 years GDM diagnoses: 24.12 ± 4.6 weeks BMI = 31.4 ± 4.8 kg/m2 (pregestational)ADA, 2004Intervention (n = 27): LGI diet* Energy: 1,477.4 ± 400.8 kcal/day CHO: 49.3 ± 6.8%; Prot: 24.1 ± 4.5%; Lip: 28 ± 5.8% GI: 47.5 ± 6.5 GL: NA Fiber: NAIntervention Total weight gain: 4.1 ± 4.9 kg Cesarean: 20 (83.3%) Labor induction: NA Insulin use: 8 patients (30%)Intervention Birth weight: 2,954 ± 649 g Macrosomia: 1 Prematurity: 3 Birth trauma: NA Hypoglycemia: NA SGA: 1
     
     Control (n = 21): all types of CHO* Energy: 1,485.4 ± 26.4 kcal/day CHO: 46.2 ± 6.2%; Prot: 24.4 ± 4.55%; Lip: 30.8 ± 6.1% GI: 47.0 ± 9.9 GL: NA Fiber: NAControl Total weight gain: 3.3 ± 3.9 kg Cesarean: 16 (76.2%) Labor induction: NA Insulin use: 9 patients (43%)Control Birth weight: 3,115 ± 469 g Macrosomia: 1 Prematurity: 2 Birth trauma: NA Hypoglycemia: NA SGA: 1
    Grant, 2011n = 47 Age = 34 ± 4 years GDM diagnoses: 27 ± 2.9 weeksNonwhite: 85% BMI = 26.5 ± 4.8 kg/m2 (pregestational)Canada, 2008Intervention (n = 23): LGI diet* Energy: NA CHO: NA; Prot: NA; Lip: NA GI: 49 ± 0.8 GL: 98.2 ± 5.1 Fiber: 30 ± 1.6 g/dayIntervention Weight gain: 0.35 ± 0.05 kg/week Cesarean: NA Labor induction: NA Insulin use: 13 patients (62%)Intervention Birth weight: 3,124 ± 124 g Macrosomia: 1 Prematurity: NA Birth trauma: NA Hypoglycemia: NA SGA: 1
     
     Control (n = 24): intermediate/high GI diet* Energy: NA CHO: NA; Prot: NA; Lip: NA GI: 58 ± 0.5 GL: 125 ± 8.8 Fiber: 23 ± 1 g/dayControl Weight gain: 0.37 ± 0.07 kg/week Cesarean: NA Labor induction: NA Insulin use: 12 patients (55%)Control Birth weight: 330 ± 220 g Macrosomia: 2 Prematurity: NA Birth trauma: NA Hypoglycemia: NA SGA: 0
    Moses, 2009n = 63 Age = 31.1 ± 4.2 years GDM diagnoses: 30.1 ± 1.1 weeks Nonwhite: 1.6% BMI = 32.4 ± 7.3 kg/m2 (at enrollment)ADIPSIntervention (n = 31): LGI* Energy: 1,713 ± 66 kcal/day CHO: 36.7 ± 1.1%; Prot: 23.9 ± 0.7%; Lip: 33.4 ± 1.2% GI: 48.0 ± 0.9 GL: NA Fiber: 25.6 ± 1.6 g/dayIntervention Total weight gain: 8.9 ± 5.0 kg Cesarean: 5 (16%) Labor induction: NA Insulin use: 9 patients (29%)Intervention Birth weight: 3,279 ± 464.5 g Macrosomia: 1 Prematurity: NA Birth trauma: NA Hypoglycemia: NA SGA: 2
     
     Control (n = 32): high GI diet* Energy: 1,664 ± 79 kcal/day CHO: 37.8 ± 1.1%; Prot: 23.5 ± 0.8%; Lip: 34.0 ± 1.8% GI: 56.0 ± 1.1 GL: NA Fiber: 22.9 ± 1.1 g/dayControl Total weight gain: 10.6 ± 7 0.0 kg Cesarean: 8 (25%) Labor induction: NA Insulin use: 19 patients (59%)Control Birth weight: 3,334 ± 431.5 g Macrosomia: 2 Prematurity: NA Birth trauma: NA Hypoglycemia: NA SGA: 0
    Louie, 2011n = 99 Age = 33.2 ± 4.3 years GDM diagnoses: 26.1 ± 4.12 weeks Nonwhite: 64.1% BMI = 24 ± 5 kg/m2 (pregestational)ADIPSIntervention (n = 47): LGI; target GI ≤50* Energy: 1,834 ± 425 kcal/day CHO: 39%; Prot: 23%; Lip: 35% GI: 47 ± 1 GL: 84 ± 3 Fiber: 27 ± 1 g/dayIntervention Total weight gain: 11.9 ± 0.7 kg Cesarean: 10 (21%) Labor induction: NA Insulin use: 25 patients (53.2%)Intervention Birth weight: 3.3 ± 0.1 kg Macrosomia: 1 Prematurity: NA Birth trauma: NA Hypoglycemia: NA SGA: 5
     
     Control (n = 45): moderate GI and high fiber diet; target GI ∼60* Energy: 1,932 ± 476.3 kcal/day CHO: 40%; Prot: 22%; Lip: 35% GI: 53 ± 1 GL: 105 ± 4 Fiber: 25 ± 1 g/dayControl Total weight gain: 13.1 ± 0.9 kg Cesarean: 5 (11%) Labor induction: NA Insulin use: 29 patients (65.1)Control Birth weight: 3.3 ± 0.1 g Macrosomia: 3 Prematurity: NA Birth trauma: NA Hypoglycemia: NA SGA: 4
    Dietary intervention: total energy restriction
    Garner, 1997n = 300 Age = 30.7 ± 4.6 years GDM diagnoses: 24–30 weeksHatem criteriaIntervention (n = 149): calorie-restricted diet§ Energy: 35 kcal/ideal body weight (kg)/dayIntervention Weight gain: 12.54 kg Cesarean: 30 (20.1%) Labor induction: NA Insulin use: 36 patients (24.2%)Intervention Birth weight: 3,437 ± 575 g Macrosomia: 24 (16.1%) Prematurity: NA Birth trauma: 0 Hypoglycemia: 21 (14.1%) SGA: NA
     
     Control (n = 150): Canada Food Guide recommendationsControl Weight gain: 13.37 kg Cesarean: 28 (18.6%) Labor induction: NA Insulin use: NAControl Birth weight: 3,544 ± 601 g Macrosomia: 28 (18.7%) Prematurity: NA Birth trauma: 0 Hypoglycemia: 13 (8.7%) SGA: NA
     
    Rae, 2000n = 125 Age = 30.4 years GDM diagnoses: 28.2 ± 5.3 weeks BMI = 38 ± 0.7 kg/m2 (at enrollment)OGTT fasting >100 mg/dL and/or 2 h >145 mg/dLIntervention (n = 66): moderate energy restriction (30%): 1,590–1,776 kcal* Energy: 1,566 kcal/day CHO: 42 ± 0.7%; Prot: 25 ± 0.3%; Lip: 31 ± 0.7%Intervention Weight gain: 11.56 ± 10.7 kg Cesarean: 36 (40%) Labor induction: 26 (46%) Insulin use: 11 patients (17.5%)Intervention Birth weight: 3,461 g Macrosomia: 11 (16.7%) Prematurity: 14 (22.2%) Birth trauma: NA Hypoglycemia: 25 (37.3%) SGA: NA
     
     Control (n = 58): not energy-restricted diet; 2,010–2,220 kcal* Energy: 1,630 kcal/day CHO: 41 ± 0.6%; Prot: 24 ± 0.3%; Lip: 34 ± 0.7%Control Weight gain: 9.68 ± 11.04 kg Cesarean: 19 (33.9%) Labor induction: 23 (45.2%) Insulin use: 9 patients (16.75%)Control Birth weight: 3,267 g Macrosomia: 6 (10.7%) Prematurity: 13 (22.1%) Birth trauma: NA Hypoglycemia: 29 (50%) SGA: NA
    Dietary intervention: low carbohydrate
    Moreno-Castilla, 2013n = 152 Age = 32.8 ± 4.1 years GDM diagnoses: 30.3 ± 3.3 weeks Nonwhite 5% BMI = 26 ± 5.6 kg/m2 (pregestational)National Diabetes Group criteriaIntervention (n = 75): low carbohydrate diet (40%) Energy: >1,800 kcal/day CHO: 40%; Prot: 20%; Lip: 40%Intervention Weight gain: 1.4 ± 2 kg Cesarean: 25 (33.8%) Labor induction: NA Insulin use: 41 (54.7%)Intervention Birth weight: NA Macrosomia: 1 Prematurity: NA Birth trauma: NA Hypoglycemia: NA SGA: 12
     
     Control (n = 75): high carbohydrate diet (∼60%)§ Energy: >1,800 kcal/day CHO: 55%; Prot: 20%; Lip: 25%Control Weight gain: 2.3 ± 2.1 kg Cesarean: 20 (26.7%) Labor induction: NA Insulin use: 41 (54.7%)Control Birth weight: NA Macrosomia: 4 Prematurity: NA Birth trauma: NA Hypoglycemia: NA SGA: 8
    Cypryk, 2007n = 30 Age = 28.7 ± 3.7 years GDM diagnoses: 29.2 ± 5.4 weeks All whiteWHO criteriaIntervention (n = 15): low carbohydrate diet (∼45%)§ Energy: NA CHO: 45%; Prot: 25%; Lip: 30%Intervention Weight gain: NA Cesarean: 7 (47%) Labor induction: NA Insulin use: 2 (13%)Intervention Birth weight: 3,407 ± 309 g Macrosomia: 0 Prematurity: NA Birth trauma: NA Hypoglycemia: NA SGA: NA
     
     Control (n = 15): high carbohydrate diet (∼60%)§ Energy: NA CHO: 60%; Prot: 25%; Lip: 15%Control Weight gain: NA Cesarean: 5 (33%) Labor induction: NA Insulin use: 1 (7%)Control Birth weight: 3,385 ± 418 g Macrosomia: 2 Prematurity: NA Birth trauma: NA Hypoglycemia: NA SGA: NA
    Dietary intervention: others
    Valentini, 2012n = 20 Age = 29.6 ± 4 years GDM diagnoses: 24.2 ± 6.9 weeks BMI = 24.9 ± 4.2 kg/m2(pregestational)Fourth International Workshop Conference on GDMIntervention (n = 10): ethnic meal plan§ Energy: 1,800–2,200 kcal/day CHO: 55%; Prot: 17%; Lip: 28% Fiber: 21 g/dayIntervention Weight gain: 12.1 ± 4.3 kg Cesarean: 6 Labor induction: NA Insulin use: 2 (20%)Intervention Birth weight: 3,064 ± 626 g Macrosomia: 0 Prematurity: NA Birth trauma: NA Hypoglycemia: NA SGA: 1
     
     Control (n = 10): ADA recommendations§ Energy: 1,800–2,200 kcal/day CHO: 53%; Prot: 18%; Lip: 28% Fiber: 26 g/dayControl Weight gain: 14.3 ± 6.9 kg Cesarean: 5 Labor induction: NA Insulin use: 1 (10%)Control Birth weight: 3,434 ± 649 g Macrosomia: 2 Prematurity: NA Birth trauma: NA Hypoglycemia: NA SGA: 0
    • ADIPS, Australasian Diabetes in Pregnancy Society; CHO, carbohydrates; GL, glycemic load; Lip, lipids; LGI, low GI; OGTT, oral glucose tolerance test; Prot, protein; WHO, World Health Organization.

    • ↵*Actual intake.

    • ↵§Dietary prescription.

PreviousNext
Back to top
Diabetes Care: 37 (12)

In this Issue

December 2014, 37(12)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by Author
  • Masthead (PDF)
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes Care.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Dietary Intervention in Patients With Gestational Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Clinical Trials on Maternal and Newborn Outcomes
(Your Name) has forwarded a page to you from Diabetes Care
(Your Name) thought you would like to see this page from the Diabetes Care web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Dietary Intervention in Patients With Gestational Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Clinical Trials on Maternal and Newborn Outcomes
Luciana Verçoza Viana, Jorge Luiz Gross, Mirela Jobim Azevedo
Diabetes Care Dec 2014, 37 (12) 3345-3355; DOI: 10.2337/dc14-1530

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Dietary Intervention in Patients With Gestational Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Clinical Trials on Maternal and Newborn Outcomes
Luciana Verçoza Viana, Jorge Luiz Gross, Mirela Jobim Azevedo
Diabetes Care Dec 2014, 37 (12) 3345-3355; DOI: 10.2337/dc14-1530
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Research Design and Methods
    • Results
    • Conclusions
    • Article Information
    • Footnotes
    • References
  • Figures & Tables
  • Suppl Material
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Accuracy of 1-Hour Plasma Glucose During the Oral Glucose Tolerance Test in Diagnosis of Type 2 Diabetes in Adults: A Meta-analysis
  • Effects of Vitamin C Supplementation on Glycemic Control and Cardiovascular Risk Factors in People With Type 2 Diabetes: A GRADE-Assessed Systematic Review and Meta-analysis of Randomized Controlled Trials
  • HbA1c Change and Diabetic Retinopathy During GLP-1 Receptor Agonist Cardiovascular Outcome Trials: A Meta-analysis and Meta-regression
Show more Meta-analysis

Similar Articles

Navigate

  • Current Issue
  • Standards of Care Guidelines
  • Online Ahead of Print
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Care Print ISSN: 0149-5992, Online ISSN: 1935-5548.